- Benzinga•7 hours ago
The market for implantable medical devices — pacemakers, defibrillators, hearing aids and other machines that help the body run — is expected to hit $26.75 billion by 2022, according to a new market research ...
Jim Cramer rattles off his take on caller favorite stocks, including this health care giant.
- Zacks•5 days ago
The Zacks Analyst Blog Highlights: IBM, Abbott, Dow Chemical, Delta Air Lines and Exelon
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||43.76 - 44.39|
|52 Week Range||36.76 - 45.84|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||46.70|
|Dividend & Yield||1.06 (2.45%)|
|1y Target Est||N/A|